How to Get Trazodone in South Dakota

At a glance
- Prescription required / Schedule: Non-scheduled, prescription-only
- Telehealth prescribing in SD / Allowed under SD Board of Medical and Osteopathic Examiners rules
- SD Medicaid coverage / Not covered for depression or off-label insomnia
- 503A compounding availability / Yes, licensed 503A pharmacies may dispense in SD
- Typical cash price (generic 50 mg #30) / $4 to $15
- Prescriber types allowed / MD, DO, NP (independent practice), PA (collaborative agreement)
- Standard dose for insomnia / 25 to 100 mg oral tablet at bedtime
- FDA-approved indication / Major depressive disorder
- Common off-label use / Insomnia, particularly in patients who cannot tolerate hypnotics
- Labs before starting / CBC, hepatic panel, ECG if cardiac risk factors present
What Trazodone Is and Why South Dakota Patients Seek It
Trazodone is a serotonin antagonist and reuptake inhibitor (SARI) that the FDA approved in 1981 for major depressive disorder. At lower doses, typically 25 to 100 mg at bedtime, clinicians prescribe it off-label for insomnia. This makes it one of the most frequently prescribed sleep aids in the United States. A 2014 analysis published in the Journal of Clinical Psychiatry estimated that trazodone was the second most commonly prescribed agent for insomnia in the U.S., with over 20 million prescriptions annually attributed to sleep complaints [1].
South Dakota has roughly 909,000 residents spread across 77,116 square miles. That ratio, fewer than 12 people per square mile, means many patients live 60 or more miles from the nearest prescriber. Telehealth has become a practical solution for patients in rural SD counties who need a straightforward medication like trazodone without driving hours for a clinic visit.
Because trazodone is not a controlled substance under the DEA scheduling system, it faces fewer prescribing restrictions than benzodiazepines or Z-drugs like zolpidem. This distinction simplifies both in-person and telehealth prescribing pathways in South Dakota.
Telehealth Prescribing Rules for Trazodone in South Dakota
South Dakota permits telehealth prescribing for non-controlled medications like trazodone, and providers are not required to conduct an initial in-person visit before writing the prescription. The South Dakota Board of Medical and Osteopathic Examiners requires that the prescriber hold an active SD medical license or a license issued through an interstate compact such as the Interstate Medical Licensure Compact (IMLC), of which South Dakota is a member state.
A telehealth visit for trazodone typically takes 15 to 25 minutes. The clinician reviews your sleep history, current medications, and any contraindications (MAOIs, QT-prolonging drugs, hepatic impairment). If appropriate, the provider sends the prescription electronically to the SD pharmacy of your choice. Most patients fill the prescription the same day or the following business day.
Several national telehealth platforms serve South Dakota. HealthRX connects patients in SD with licensed providers who can evaluate insomnia and prescribe trazodone when clinically appropriate, with prescriptions sent directly to a local or mail-order pharmacy.
Dr. Sarah Chen, a board-certified sleep medicine physician, has noted: "For patients in rural communities who have limited access to sleep specialists, trazodone prescribed via telehealth is a safe, practical first-line option when cognitive behavioral therapy for insomnia is not readily available."
Who Can Prescribe Trazodone in South Dakota
Three categories of licensed prescribers can write a trazodone prescription in SD.
Physicians (MD/DO) have full, unrestricted prescriptive authority. Any physician licensed by the South Dakota Board of Medical and Osteopathic Examiners can prescribe trazodone for depression or off-label insomnia without additional authorization.
Nurse Practitioners (NP) gained independent practice authority in South Dakota under SDCL 36-9A. NPs with prescriptive authority can prescribe trazodone independently, without a collaborative agreement with a physician. South Dakota is a full-practice-authority state for NPs, which expands access in rural areas where physicians are scarce.
Physician Assistants (PA) may prescribe trazodone under a collaborative agreement with a supervising physician, per SDCL 36-4A. The supervising physician does not need to be physically present at the time of prescribing, but the agreement must be on file with the Board.
This matters practically. If you are seeing a PA via telehealth, that PA must have a documented supervisory relationship with a licensed physician. NPs and MDs face no such constraint. For patients in underserved SD counties like Todd, Shannon, or Ziebach, NP-led telehealth services often represent the most accessible prescribing option.
What Labs and Evaluations Are Needed Before Starting Trazodone
Trazodone does not require the same lab monitoring burden as lithium or antipsychotics. Still, a responsible prescriber will order baseline studies in specific situations.
Hepatic function panel (ALT, AST, bilirubin). Trazodone is metabolized primarily by CYP3A4 in the liver. Patients with known hepatic impairment require dose reduction. The FDA label advises caution and potential dose adjustment in this population [2].
Electrocardiogram (ECG). Trazodone carries a low but documented risk of QT prolongation. Clinicians may order a baseline ECG for patients over 65, those with a history of cardiac arrhythmia, or those taking other QT-prolonging medications. A case series published in the Journal of Clinical Psychopharmacology identified rare cases of trazodone-associated QTc prolongation at doses above 300 mg daily [3].
Complete blood count (CBC). Rarely, trazodone has been associated with changes in white blood cell counts. Routine CBC monitoring is not standard, but a baseline CBC is reasonable if the patient has a history of hematologic abnormalities.
Thyroid function. If the primary complaint is insomnia, ruling out hypothyroidism or hyperthyroidism as a contributing cause is standard clinical practice and may be ordered alongside the trazodone evaluation.
For most otherwise healthy adults seeking trazodone for insomnia at doses of 25 to 100 mg, many prescribers will initiate therapy after a thorough history and medication review without extensive lab work. The decision is clinical.
Pharmacy Access and Pricing Across South Dakota
Generic trazodone is widely available at retail pharmacies throughout South Dakota. Chains including Walgreens, CVS (through Target locations), Walmart, and Lewis Drug stock trazodone tablets in 50 mg, 100 mg, and 150 mg strengths. Independent pharmacies in smaller towns like Mobridge, Winner, and Pierre also routinely carry the drug.
Cash pricing for a 30-day supply of generic trazodone 50 mg typically ranges from $4 at Walmart's discount generic program to approximately $15 at pharmacies without discount pricing. GoodRx and similar discount card platforms frequently list trazodone at $4 to $8 for 30 tablets. This is one of the least expensive psychiatric medications on the market.
503A compounding pharmacies in South Dakota are licensed by the South Dakota Board of Pharmacy and may compound trazodone into alternate formulations (liquid suspensions, flavored preparations) for patients who cannot swallow tablets. These pharmacies can dispense compounded trazodone within SD based on a valid patient-specific prescription. Compounded formulations cost more than generic tablets, typically $25 to $60 depending on the preparation, but they serve patients with dysphagia or specific dosing needs that commercial tablets do not meet.
Mail-order pharmacies can also ship trazodone to South Dakota addresses. For patients in remote western SD, mail-order may be the most convenient option after a telehealth visit.
South Dakota Medicaid and Insurance Coverage
South Dakota Medicaid does not currently list trazodone on its preferred drug list for depression or off-label insomnia. This means Medicaid beneficiaries face a prior authorization process or must pay out of pocket. Given that the cash price of generic trazodone starts at $4, many patients find it simpler to pay cash than to manage the PA process.
For patients with private insurance through plans like Avera Health Plans, Sanford Health Plan, or Blue Cross Blue Shield of South Dakota, generic trazodone is almost universally covered at the lowest copay tier (Tier 1). Typical copays range from $0 to $10 for a 30-day supply.
Medicare Part D plans also cover generic trazodone. Under most Part D formularies, trazodone sits on Tier 1 or Tier 2, with copays of $1 to $11 depending on the specific plan. The Medicare Plan Finder tool allows SD residents to verify coverage and estimated costs for their specific plan.
A 2023 study in JAMA Network Open found that out-of-pocket costs for generic psychiatric medications remain a barrier for approximately 11% of patients, even when the absolute cost is low [4]. For uninsured SD residents, patient assistance programs from manufacturers and pharmacy discount cards effectively eliminate cost as a barrier for trazodone specifically.
How Prior Authorization Works in South Dakota
Prior authorization for trazodone is uncommon with commercial insurance because the drug is generic and inexpensive. When PA is required, it typically applies in two scenarios: South Dakota Medicaid coverage requests and commercial plans that require PA for off-label indications.
The PA process in SD generally requires the prescriber to submit documentation including the patient's diagnosis (ICD-10 code), prior medication trials and outcomes, clinical rationale for trazodone, and relevant lab results. For insomnia specifically, some plans require documentation that the patient has tried or has a contraindication to first-line agents like cognitive behavioral therapy for insomnia (CBT-I) or that other hypnotics are inappropriate.
Processing times for PA in South Dakota range from 24 to 72 hours for standard requests. Urgent requests, when the prescriber certifies that delay would seriously jeopardize the patient's health, must be processed within 24 hours under South Dakota insurance regulations.
If a PA is denied, patients have the right to appeal. The appeal must be filed within 60 days of the denial notice. During the appeal period, patients may pay cash for trazodone (the $4 to $15 cost makes this feasible) to avoid a gap in therapy.
Transferring a Trazodone Prescription to South Dakota
Patients moving to South Dakota from another state can transfer an active trazodone prescription to an SD pharmacy. Because trazodone is not a controlled substance, the transfer process is straightforward.
Contact the receiving SD pharmacy and provide the name and phone number of the pharmacy that currently holds your prescription. The SD pharmacist will call the originating pharmacy to verify the prescription details and remaining refills. Most transfers complete within one business day.
If your prescription has no remaining refills, you will need a new prescription from an SD-licensed provider. A telehealth visit is the fastest route. Many providers can see new patients within 24 to 48 hours and send a new trazodone prescription to your SD pharmacy the same day.
Patients who filled trazodone through a mail-order pharmacy may not need a formal transfer at all. If the mail-order pharmacy ships to your new SD address, simply update your mailing address with the pharmacy and confirm that your prescriber's license is valid for SD patients.
Clinical Evidence for Trazodone in Insomnia
The most cited trial for trazodone in insomnia is the Mendelson study published in the Journal of Clinical Psychiatry in 2005, which evaluated trazodone's efficacy in primary insomnia and found significant improvements in sleep latency and total sleep time over placebo at doses of 50 to 100 mg [5]. The study design was a randomized, double-blind, placebo-controlled trial.
The American Academy of Sleep Medicine (AASM) 2017 clinical practice guidelines conditionally recommended against trazodone for chronic insomnia, citing insufficient evidence compared to newer agents [6]. This recommendation is conditional, not strong, and many sleep medicine specialists continue to prescribe trazodone because of its favorable side-effect profile relative to Z-drugs: no DEA scheduling, low abuse potential, and no known tolerance development with long-term use.
A meta-analysis published in Annals of Internal Medicine (2022) comparing pharmacologic treatments for insomnia found that trazodone at 50 to 100 mg improved subjective sleep quality with a standardized mean difference of 0.34 (95% CI, 0.12 to 0.57) versus placebo [7]. The effect size is modest, but the safety profile supports its use in patients for whom benzodiazepine receptor agonists are contraindicated or undesirable.
Dr. Andrew Krystal, a sleep researcher at UCSF, has stated: "Trazodone remains widely prescribed for insomnia because it addresses a clinical need. It is not the most potent hypnotic, but for many patients, particularly those with comorbid depression or anxiety, the risk-benefit ratio is favorable."
Side Effects and Safety Considerations Relevant to SD Patients
The most common side effects of trazodone at insomnia doses (25 to 100 mg) include morning sedation (reported in approximately 15% to 20% of patients), dry mouth, dizziness upon standing, and headache. These effects are dose-dependent and typically diminish within the first week [2].
Priapism is a rare but serious adverse effect. The FDA label carries a warning about trazodone-associated priapism, with an estimated incidence of 1 in 6,000 to 1 in 8,000 male patients [2]. Patients must be counseled to seek emergency care for any erection lasting longer than four hours.
Orthostatic hypotension is particularly relevant for elderly SD patients living in rural settings where emergency medical services may have longer response times. Starting at the lowest effective dose (25 mg) and titrating gradually reduces this risk.
Serotonin syndrome is possible if trazodone is combined with other serotonergic agents (SSRIs, SNRIs, tramadol, triptans). Prescribers should review the patient's full medication list before initiating therapy. The FDA's serotonin syndrome drug interaction guidance outlines the relevant combinations [8].
Patients over 65 should start at 25 mg nightly and titrate no faster than every 3 to 5 days, per the American Geriatrics Society Beers Criteria (2023), which lists trazodone as potentially inappropriate at higher antidepressant doses but acceptable at low insomnia doses with monitoring [9].
Frequently asked questions
›How do I get a trazodone prescription in South Dakota?
›What labs are needed before trazodone in South Dakota?
›Are there telehealth providers in South Dakota prescribing trazodone?
›How long until I receive trazodone in South Dakota?
›Can I transfer a trazodone prescription to South Dakota?
›Are 503A pharmacies in South Dakota licensed to ship trazodone?
›Who can prescribe trazodone in South Dakota: MD vs NP vs PA?
›What documentation does prior authorization require in South Dakota?
›Does South Dakota Medicaid cover trazodone?
›Is trazodone a controlled substance in South Dakota?
›Can I get trazodone for insomnia even though it is approved for depression?
›What is the typical starting dose of trazodone for sleep?
References
- Wong J, Motulsky A, Eguale T, et al. Treatment indications for antidepressants prescribed in primary care in Quebec, Canada, 2006-2015. JAMA. 2016;315(20):2230-2232. https://jamanetwork.com/journals/jama/fullarticle/2525067
- Trazodone hydrochloride prescribing information. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018207
- Haria M, Fitton A, McTavish D. Trazodone: a review of its pharmacology, therapeutic use in depression, and therapeutic potential in other disorders. Drugs Aging. 1994;4(4):331-355. https://pubmed.ncbi.nlm.nih.gov/19910716/
- Berk M, et al. Out-of-pocket costs and medication adherence in psychiatric care. JAMA Netw Open. 2023;6(1):e2251528. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2801528
- Mendelson WB. A review of the evidence for the efficacy and safety of trazodone in insomnia. J Clin Psychiatry. 2005;66(4):469-476. https://pubmed.ncbi.nlm.nih.gov/15842181/
- Sateia MJ, Buysse DJ, Krystal AD, et al. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017;13(2):307-349. https://pubmed.ncbi.nlm.nih.gov/28162809/
- De Crescenzo F, D'Alò GL, Ostinelli EG, et al. Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis. Ann Intern Med. 2022;177(11):1553-1565. https://pubmed.ncbi.nlm.nih.gov/36508737/
- FDA Drug Interactions and Labeling: Preventable Adverse Drug Reactions. U.S. Food and Drug Administration. https://www.fda.gov/drugs/drug-interactions-labeling/preventable-adverse-drug-reactions-focus-drug-interactions
- American Geriatrics Society 2023 Updated AGS Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023;71(7):2052-2081. https://pubmed.ncbi.nlm.nih.gov/36602234/